Overview

Update
Status
Aviir has been closed
Total Equity Funding
$62.93M in 13 Rounds from 4 Investors
Headquarters:
Irvine, CA
Description:
Aviir provides cardio metabolic tests and services for the prevention and management of cardiovascular diseases.
Categories:
Pharmaceutical, Biotechnology, Health Diagnostics
Website:
http://www.aviir.com
Social:

Company Details

Update

Aviir is a venture-funded biotechnology company developing cutting-edge, diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology is based on ten years of research at Stanford University, and combines the scientific founder’s deep understanding of biomarker assay development and advanced biostatistics. Aviir has pursued an aggressive commercialization strategy, and initial products, including the MIRISK VP™ test, are currently on the market. The Aviir leadership team includes the founding scientists and highly experienced management.

Funding Rounds (14) - $70.93M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2013$10M / Series B4
Feb, 2013$10M / Series B4
Sep, 2012$8M / Debt Financing1
Dec, 2011$10M / Series B4
Jun, 2011$3M / Venture3
Jan, 2010$4.2M / Venture3
Oct, 2009$1M / Venture3
Aug, 2009$1M / Venture3
Dec, 2008$7.8M / Venture3
Mar, 2008$1.5M / Venture0
Sep, 2007$11.35M / Venture3
Aug, 2007$1.45M / Convertible Note0
Mar, 2007$130k / Venture0
Oct, 2006$1.5M / Venture0

News (20)

Update

Offices/Locations (1)

Update
  • Office

    9805 Research Drive

    Irvine, CA 92618

    USA

Past Team (11)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos